Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
NCT00257660 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 116
Last updated 2022-09-28
Summary
The aim of this study is to demonstrate the effectiveness and safety of 500 units of Dysport manufactured at a new manufacturing facility in Europe.
Conditions
- Cervical Dystonia
Interventions
- BIOLOGICAL
-
Botulinum toxin type A
500 units
- DRUG
-
500 units
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Ipsen Medical Director · Ipsen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-10
- Primary Completion
- 2006-09-30
- Completion
- 2006-09-30
Countries
- United States
- Russia
Study Locations
More Related Trials
-
A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia
NCT00950664 ·Status: COMPLETED ·Phase: PHASE4
-
Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm]
NCT01840462 ·Status: COMPLETED
-
Conversion to Dysport in CD
NCT04270214 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Waning of Botulinum Toxin in the Treatment of Cervical Dystonia
NCT06886750 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia
NCT01314365 ·Status: COMPLETED
-
Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia
NCT01588574 ·Status: COMPLETED ·Phase: PHASE2
-
Dysport for the Treatment of OMD
NCT01921270 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dysport® Adult Upper Limb Spasticity
NCT01313299 ·Status: COMPLETED ·Phase: PHASE3
-
A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor
NCT03136341 ·Status: RECRUITING ·Phase: PHASE4
-
Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain
NCT02221648 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of MEDITOXIN® in Cervical Dystonia
NCT03905304 ·Status: COMPLETED ·Phase: PHASE3
-
Dysport® Adult Upper Limb Spasticity Extension Study
NCT01313312 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Botulinum Toxin in Cervical Dystonia
NCT01056861 ·Status: COMPLETED
-
Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)
NCT02969356 ·Status: COMPLETED ·Phase: PHASE4
-
Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
NCT01357980 ·Status: COMPLETED ·Phase: PHASE2
-
PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia
NCT00549341 ·Status: COMPLETED ·Phase: PHASE1
-
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia
NCT00407030 ·Status: COMPLETED ·Phase: PHASE3
-
" Treating MS Patients With Lower Extremity Spasticity Using Dysport"
NCT03585569 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
NCT00134810 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm
NCT00276315 ·Status: COMPLETED ·Phase: PHASE3
-
Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia
NCT03805152 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity
NCT03017729 ·Status: COMPLETED
-
Motor and Non-motor Symptoms in Cervical Dystonia
NCT04560101 ·Status: UNKNOWN
-
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
NCT00578097 ·Status: TERMINATED ·Phase: PHASE2
-
Dysport® Adult Lower Limb Spasticity Study
NCT01249404 ·Status: COMPLETED ·Phase: PHASE3